\
&
Contact us
Published on | 3 weeks ago
Programmes Digital, Industry & Space Digital EuropeThe European Commission's Directorate-General for Communications Networks, Content and Technology (DG CONNECT) organises a series of events to showcase how the International Digital Strategy of the EU is implemented.
The events address policy makers, industry experts, academics, and anyone interested in the intersection of EU digital policy and international affairs and aim to provide insights on how to leverage international partnerships to boost EU’s tech competitiveness and promote a high level of security for the EU and its partners.
More information on the event series can be found here.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.